Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Revenue: 2014-2020

Historic Revenue for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to -$301,000.

  • Larimar Therapeutics' Revenue rose 39.80% to -$301,000 in Q1 2020 from the same period last year, while for Mar 2020 it was -$1.6 million, marking a year-over-year increase of 19.23%. This contributed to the annual value of -$1.8 million for FY2019, which is 6.95% up from last year.
  • Larimar Therapeutics' Revenue amounted to -$301,000 in Q1 2020, which was up 16.85% from -$362,000 recorded in Q4 2019.
  • In the past 5 years, Larimar Therapeutics' Revenue ranged from a high of -$8,000 in Q4 2017 and a low of -$500,000 during Q1 2019.
  • Moreover, its 3-year median value for Revenue was -$466,000 (2018), whereas its average is -$440,556.
  • Per our database at Business Quant, Larimar Therapeutics' Revenue spiked by 91.75% in 2017 and then slumped by 6,137.50% in 2018.
  • Larimar Therapeutics' Revenue (Quarterly) stood at -$97,000 in 2016, then soared by 91.75% to -$8,000 in 2017, then slumped by 6,137.50% to -$499,000 in 2018, then rose by 27.45% to -$362,000 in 2019, then surged by 39.80% to -$301,000 in 2020.
  • Its last three reported values are -$301,000 in Q1 2020, -$362,000 for Q4 2019, and -$426,000 during Q3 2019.